Bielenica Anna, Struga Marta, Mirosław Barbara, Kozioł Anna E, Kossakowski Jerzy, Sanna Giuseppina, La Colla Paolo, Giliberti Gabriele
Department of Medical Chemistry, The Medical University of Warsaw, 3 Oczki Street, 02-007 Warszawa, Poland.
Acta Pol Pharm. 2013 Sep-Oct;70(5):809-22.
The preparation of 16 derivatives of 3,5,8-trioxo-4-azatricyclo- [5.2.2.0(2.6)]undec-1-yl acetate and 8 derivatives of 1-isobutoxy-4-azatricyclo[5.2.2.0(2.6)]undecane-3,5,8-trione was described. Substituents to the imide N-atom were alkyl-(aryl)piperazine fragments with an alkyl linker being propyl or butyl group. Selected newly obtained compounds were evaluated in vitro against anti-HIV-1 activity. A broad group o fderivatives were tested for their antibacterial and antifungal activity. The pharmacological properties of butyl derivatives of imide 6 were evaluated in three behavioral tests in mice. The molecular structures of starting polycyclic 6-acetyl-imides, 1 and 5, were determined by X-ray crystallography. Presented tests have not revealed any activity of the compounds, however, selected derivatives exerted no neurotoxicity in behavioral tests.
描述了3,5,8 - 三氧代 - 4 - 氮杂三环[5.2.2.0(2.6)]十一 - 1 - 基乙酸酯的16种衍生物以及1 - 异丁氧基 - 4 - 氮杂三环[5.2.2.0(2.6)]十一烷 - 3,5,8 - 三酮的8种衍生物的制备方法。酰亚胺N原子上的取代基为带有丙基或丁基烷基连接基的烷基 -(芳基)哌嗪片段。对新得到的部分化合物进行了抗HIV - 1活性的体外评估。对一大类衍生物进行了抗菌和抗真菌活性测试。在小鼠的三项行为测试中评估了酰亚胺6的丁基衍生物的药理特性。通过X射线晶体学确定了起始多环6 - 乙酰基 - 酰亚胺1和5的分子结构。所进行的测试未揭示这些化合物的任何活性,然而,所选衍生物在行为测试中未表现出神经毒性。